Veteran finance and corporate strategist focused on growth-stage technology and healthcare investments, combining operating experience with board-level governance and capital-raising expertise. Krista D. McBeath brings experience in strategic M&A advisory, portfolio company scaling, and investor relations, with a track record of working across private equity, venture and corporate development teams to drive value creation and exit outcomes.
Veteran finance and corporate strategist focused on growth-stage technology and healthcare investments, combining operating experience with board-level governance and capital-raising expertise. Krista D. McBeath brings experience in strategic M&A advisory, portfolio company scaling, and investor relations, with a track record of working across private equity, venture and corporate development teams to drive value creation and exit outcomes.
Combines an operator-led, growth-stage investment approach emphasizing scalable technology and healthcare businesses. Prioritizes capital-efficient models, repeatable go-to-market strategies, and governance-ready leadership teams; favors active board engagement, staged capital deployment tied to operational milestones, and disciplined exit planning. Underwrites opportunities with an integrated M&A and capital markets lens, blending venture-like upside with private equity value-creation levers—product-market fit, commercial scaling, and strategic partnerships. Time horizon targets growth-to-exit (3–7 years) with emphasis on risk-managed concentration and measurable KPIs to drive dilution-aware returns.
Combines an operator-led, growth-stage investment approach emphasizing scalable technology and healthcare businesses. Prioritizes capital-efficient models, repeatable go-to-market strategies, and governance-ready leadership teams; favors active board engagement, staged capital deployment tied to operational milestones, and disciplined exit planning. Underwrites opportunities with an integrated M&A and capital markets lens, blending venture-like upside with private equity value-creation levers—product-market fit, commercial scaling, and strategic partnerships. Time horizon targets growth-to-exit (3–7 years) with emphasis on risk-managed concentration and measurable KPIs to drive dilution-aware returns.
| Trades 348 | Longs Won 241/348 69% | Profit Factor 15.12 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $711,526.65 |
| Average Win $248,281.36 | Best Trade (Oct 14) $9.43M | Sharpe Ratio 0.46 |
| Average Loss -$36,992.98 | Worst Trade (Oct 14) -$810,870.06 | Z-Score -1.6 (89.87%) |
| Commissions $0 | Avg. Trade Length 1y 1m 4d | Expectancy $160,567.69 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 8,197 | 7,377 | 6,557 | 5,738 | 4,918 | 4,098 | 3,279 | 2,459 | 1,639 | 820 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 34,757 | $7.1M | $11.93M | - | $4.83M | 68.13% | +0.093% |
AVEM Avantis Emerging Markets Equity ETF | 2,418 | $233,313 | $217,813.44 | - | -$15,499.56 | -6.64% | -1.033% |
BRK-A Berkshire Hathaway Inc. | 2 | $1.09M | $1.58M | - | $499,360 | 46.01% | +0.344% |
BRK-B Berkshire Hathaway Inc. | 3,476 | $1.3M | $1.84M | - | $540,225.92 | 41.62% | +0.478% |
CAT Caterpillar Inc. | 633 | $380,206.76 | $462,340.03 | - | $82,133.27 | 21.6% | -2.481% |
CERY SPDR Bloomberg Enhanced Roll Yield Commodity Strategy No K-1 ETF | 165,718 | $5.08M | $6.66M | - | $1.58M | 31.17% | -0.162% |
DFAE Dimensional Emerging Core Equity Market ETF | 7,050 | $182,386.35 | $265,961.25 | - | $83,574.9 | 45.82% | -1.166% |
DFAI Dimensional International Core Equity Market ETF | 20,172 | $628,533.4 | $834,213.06 | - | $205,679.66 | 32.72% | +0.401% |
DSTL Distillate U.S. Fundamental Stability & Value ETF | 10,102 | $573,086.46 | $686,329.88 | - | $113,243.42 | 19.76% | +2.59% |
EBND SPDR Bloomberg Emerging Markets Local Bond ETF | 63,697 | $1.28M | $1.32M | - | $38,444.87 | 3% | +0.388% |
EMHC SPDR Bloomberg Emerging Markets USD Bond ETF | 100,315 | $2.42M | $2.42M | - | -$2,329.6 | -0.1% | +0.668% |
FISR SPDR SSGA Fixed Income Sector Rotation ETF | 288,333 | $7.45M | $7.11M | - | -$344,709.82 | -4.63% | +0.53% |
FLQM Franklin U.S. Mid Cap Multifactor Index Fund | 7,715 | $395,705.22 | $465,561.67 | - | $69,856.45 | 17.65% | +1.814% |
GLD SPDR Gold Shares | 8,531 | $2.25M | $3.25M | - | $994,661.4 | 44.2% | +1.172% |
GTO Invesco Total Return Bond ETF | 22,352 | $1.07M | $1.01M | - | -$60,281.27 | -5.65% | +0.446% |
GWX SPDR S&P International Small Cap ETF | 78,577 | $2.62M | $3.49M | - | $864,700.32 | 32.99% | -0.794% |
IAGG iShares International Aggregate Bond Fund | 398,519 | $20.02M | $19.65M | - | -$365,737.89 | -1.83% | +0.173% |
INTF iShares International Equity Factor ETF | 31,371 | $916,974.67 | $1.3M | - | $378,490.77 | 41.28% | +0.474% |
IUSB iShares Core Universal USD Bond ETF | 728,740 | $33.59M | $32.4M | - | -$1.18M | -3.52% | +0.509% |
JNK SPDR Bloomberg High Yield Bond ETF | 61,598 | $5.94M | $5.7M | - | -$247,238.51 | -4.16% | +0.266% |